Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 29, 2005
Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsionMichel White, Haissam Haddad, Marie-Hélène Leblanc, et al.
The Canadian Journal of Cardiology|November 14, 2021
Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH RegistryGabrielle Roy, Patrick Couture, Jacques Genest, et al.
American Journal of Obstetrics and Gynecology|December 17, 2008
Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia StudySusan R Kahn, Robert Platt, Helen McNamara, et al.
Atherosclerosis|February 5, 2026
Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotypeG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
The Journal of Biological Chemistry|October 6, 2006
Correction of apolipoprotein A-I-mediated lipid efflux and high density lipoprotein particle formation in human Niemann-Pick type C disease fibroblastsEmmanuel Boadu, Hong Y Choi, Diana W K Lee, et al.
The Canadian Journal of Cardiology|December 3, 2014
Canadian Cardiovascular Society position statement on familial hypercholesterolemia, Jacques Genest, Robert A Hegele, et al.
Atherosclerosis|October 2, 2018
Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registryLiam R Brunham, Isabelle Ruel, Etienne Khoury, et al.
Lancet (London, England)|March 31, 2009
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trialPaul M Ridker, Eleanor Danielson, Francisco Ah Fonseca, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER)Paul M Ridker, Jean G MacFadyen, Francisco A H Fonseca, et al.
The American Journal of Cardiology|November 27, 2007
Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive proteinPaul M Ridker, Francisco A H Fonseca, Jacques Genest, et al.
Pageof 23